Catalysts for Rubicon Research Ltd
43 tracked
May 3, 2022
approval
BUPRENORPHINE HYDROCHLORIDE โ FDA approval
BUPRENORPHINE HYDROCHLORIDE
โ
Mar 4, 2021
approval
BUPRENORPHINE HYDROCHLORIDE โ FDA approval
BUPRENORPHINE HYDROCHLORIDE
โ
Jan 13, 2021
approval
TRAMADOL HYDROCHLORIDE โ FDA approval
tramadol hydrochloride ER
โ
Jan 13, 2021
approval
TRAMADOL HYDROCHLORIDE โ FDA approval
tramadol hydrochloride ER
โ
Oct 9, 2019
approval
BUPRENORPHINE HYDROCHLORIDE โ FDA approval
BUPRENORPHINE HYDROCHLORIDE
โ
Jun 28, 2019
approval
TRAMADOL HYDROCHLORIDE โ FDA approval
tramadol hydrochloride ER
โ
Oct 31, 2018
approval
BUPRENORPHINE HYDROCHLORIDE โ FDA approval
BUPRENORPHINE HYDROCHLORIDE
โ
Feb 1, 2018
approval
BUPRENORPHINE HYDROCHLORIDE โ FDA approval
BUPRENORPHINE HYDROCHLORIDE
โ
May 23, 2017
approval
BUPRENORPHINE HYDROCHLORIDE โ FDA approval
BUPRENORPHINE HYDROCHLORIDE
โ
Dec 16, 2016
approval
BUPRENORPHINE HYDROCHLORIDE โ FDA approval
BUPRENORPHINE HYDROCHLORIDE
โ
Dec 16, 2016
approval
BUPRENORPHINE HYDROCHLORIDE โ FDA approval
BUPRENORPHINE HYDROCHLORIDE
โ
Jul 7, 2016
approval
BUPRENORPHINE HYDROCHLORIDE โ FDA approval
BUPRENORPHINE HYDROCHLORIDE
โ
Jun 10, 2015
approval
BUPRENORPHINE HYDROCHLORIDE โ FDA approval
BUPRENORPHINE HYDROCHLORIDE
โ